Beijing Med-Pharm says that an entity formed by it and Alliance Boots, Europe's leading pharmacy-led health and beauty group, has agreed to acquire a 50% interest in Guangzhou Pharmaceuticals Corp, the third largest pharmaceutical wholesaler in China.
Alliance BMP, the UK-based investment vehicle formed by Alliance Boots and Beijing Med-Pharm, will take a 50% interest in GP Corp for 545.0 million renminbi ($69.0 million) in cash, constituting of a direct capital injection into the latter. Alliance Boots will own 80% of Alliance BMP and Beijing Med-Pharm 20%. Alliance BMP will hold four of the eight GP Corp board seats. David Gao, who played a key role in the negotiations for the transaction with GP Corp, will continue as chief executive of Beijing Med-Pharm, and will serve as chairman of GP Corp. The formation of Alliance BMP also creates a vehicle through which Beijing Med-Pharm and Alliance Boots can make additional investments in China.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze